JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dagirmanjian, R.
Right arrow Articles by Boyd, E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dagirmanjian, R.
Right arrow Articles by Boyd, E. S.
Journal of Pharmacology And Experimental Therapeutics, Vol. 135, Issue 1, 25-33, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


SOME PHARMACOLOGICAL EFFECTS OF TWO TETRAHYDROCANNABINOLS

R. Dagirmanjian 1 and E. S. Boyd 1

1 Department of Pharmacology, University of Rochester School of Medicine and Dentistry, Rochester, New York

In anesthetized cats, time dimethyl heptyl pyran derivative, the most potent tetrahydrocannabinol tested, lowered blood pressure, depressed respiration, relaxed the gut, and depressed two polysynaptic reflexes (the flexion and linguomandibular). The methyl octyl pyran derivative produced effects in general similar to those of DMHP, but it was shorter acting and showed stimulatomy action on time flexion reflex.

In mice, barbiturate sleeping times were prolonged significantly by DMHP and by MOP. The increased activity induced by amphetamine was also prolonged by DMHP and by MOP. The 7-day LD50's DPH mnd for MOP given intravenously were 27 mg/kg and 5.0 mg/kg, respectively.

The site of action of the effects on blood pressure and reflexes was narrowed to the area between the mesencephalon and the the level of the first cervical vertebra, possibly in the reticular formation of the medulla.

Submitted on July 3, 1961




This article has been cited by other articles:


Home page
GutHome page
R G PERTWEE
Cannabinoids and the gastrointestinal tract
Gut, June 1, 2001; 48(6): 859 - 867.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H. Kalant and A. Crancer Jr.
Marihuana and Simulated Driving
Science, October 31, 1969; 166(3905): 640 - 640.
[PDF]


Home page
ScienceHome page
D. Holtzman, R. A. Lovelil, J. H. Jaffe, and D. X. Freedman
1-dgr9-Tetrahydrocannabinol: Neurochemical and Behavioral Effects in the Mouse
Science, March 28, 1969; 163(3874): 1464 - 1467.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.